Risk of unfavorable character among neuroblastomas detected through mass screening

Medical and Pediatric Oncology

Volumn 35, Issue 6, 2000, Pages 705-707

  Tanaka, Takeo ^a,c   Matsumura, Takafumi ^b   Iehara, Tomoko ^b   Sawada, Tadashi ^b  

^a Kure National University   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c National Hospital Organization   (Japan)

Author keywords

Ha ras gene; Mass screening; Neuroblastoma; Prognostic factor; trk A gene

Indexed keywords

ADVANCED CANCER; CONFERENCE PAPER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MASS SCREENING; NEUROBLASTOMA; NEWBORN; ONCOGENE C MYB; ONCOGENE H RAS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HUMANS; INFANT; JAPAN; MASS SCREENING; NEUROBLASTOMA; PROGNOSIS; RECEPTOR, TRKA;

EID: 0033659894     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911X(20001201)35:6<705::AID-MPO48>3.0.CO;2-L     Document Type: Conference Paper

References (11)

1. Screening for neuroblastoma in infancy in Japan
2. Mass screening for neuroblastoma and mortality in birth cohorts
3. A population-based study of the usefulness of screening for neuroblastoma
4. Expression of Ha-ras oncogene products in human neuroblastomas and the significant correlation with a patient prognosis
5. trk A gene expression in neuroblastoma: The clinical significance of an immunohistochemical study
6. Prognostic discrimination among neuroblastomas according to Ha-ras / trk A gene expression
7. A trial to discriminate spontaneous regression from non-regression cases during mass screening for neuroblastoma
8. Treatment of localized neuroblastoma
9. Natural history of neuroblastoma found by mass screening
10. A case with neuroblastoma detected through infantile mass screening and recurrence 29 months after the chemotherapy
11. A neuroblastoma cell line derived from a case detected through a mass screening system in Japan